AUM Biosciences
PrivateLast Round
Reverse Merger
Jun 8, 2023
Est. Valuation
$469M
Total Funding Raised
$28.5M
Company Overview
AUM Biosciences operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series A round in October 2021.
AUM Biosciences is a biotechnology company that leverages a proprietary AI-augmented platform to systematically discover and develop targeted cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AUM Biosciences Comparables
Compare AUM Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Boundless Bio | 77% | |
| Ono Pharmaceutical Co., Ltd. | 77% | |
| Inflection Biosciences | 77% |
For institutional investors. Book with your work email.
AUM Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Reverse Merger | Jun 8, 2023 | ||||
| Series A | Oct 12, 2021 | ||||
| Seed | Jun 25, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AUM Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SPRIM Global Investments | Series A |
| SPRIM Global Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2023
$69M raised with Mountain Crest Acquisition Corp. V.
- Oct 12, 2021
$27M round led by Everlife Asia and SPRIM Global Investments.
For institutional investors. Book with your work email.
AUM Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AUM Biosciences's valuation, stock price, and market status.
Is AUM Biosciences a public or private company?
AUM Biosciences is a private company.
What is the current stock price of AUM Biosciences?
AUM Biosciences is a private company, so its shares have no public market price. Caplight tracks AUM Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AUM Biosciences worth (valuation)?
AUM Biosciences's valuation is estimated at $469.0M based on funding round data.
Can I buy AUM Biosciences stock?
AUM Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AUM Biosciences's last funding round?
AUM Biosciences's most recent funding round was Reverse Merger on June 8, 2023.
Who are the main investors in AUM Biosciences?
Key investors in AUM Biosciences include SPRIM Global Investments, SPRIM Global Investments.
Will AUM Biosciences IPO soon?
No public IPO plans have been announced for AUM Biosciences.
How can I track AUM Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in AUM Biosciences's shares on secondary markets.